- Home
- IMRN vs BFRI Comparison
IMRN vs BFRI Comparison
Compare IMRN & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- BFRI
- Stock Information
- Founded
- IMRN 1994
- BFRI 1997
- Country
- IMRN Australia
- BFRI United States
- Employees
- IMRN N/A
- BFRI N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- IMRN Health Care
- BFRI Health Care
- Exchange
- IMRN Nasdaq
- BFRI Nasdaq
- Market Cap
- IMRN 9.2M
- BFRI 7.9M
- IPO Year
- IMRN N/A
- BFRI 2021
- Fundamental
- Price
- IMRN $1.80
- BFRI $0.85
- Analyst Decision
- IMRN Strong Buy
- BFRI Strong Buy
- Analyst Count
- IMRN 1
- BFRI 1
- Target Price
- IMRN $5.00
- BFRI $2.75
- AVG Volume (30 Days)
- IMRN 46.0K
- BFRI 377.9K
- Earning Date
- IMRN 08-29-2025
- BFRI 11-12-2025
- Dividend Yield
- IMRN N/A
- BFRI N/A
- EPS Growth
- IMRN N/A
- BFRI N/A
- EPS
- IMRN N/A
- BFRI N/A
- Revenue
- IMRN $4,777,422.00
- BFRI $39,188,000.00
- Revenue This Year
- IMRN N/A
- BFRI $11.07
- Revenue Next Year
- IMRN N/A
- BFRI $11.20
- P/E Ratio
- IMRN N/A
- BFRI N/A
- Revenue Growth
- IMRN 48.63
- BFRI 11.20
- 52 Week Low
- IMRN $1.50
- BFRI $0.54
- 52 Week High
- IMRN $2.87
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- IMRN 48.13
- BFRI 46.48
- Support Level
- IMRN $1.80
- BFRI $0.81
- Resistance Level
- IMRN $1.94
- BFRI $0.90
- Average True Range (ATR)
- IMRN 0.08
- BFRI 0.05
- MACD
- IMRN -0.01
- BFRI 0.00
- Stochastic Oscillator
- IMRN 22.22
- BFRI 40.32
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.